Comparison of intracoronary adenosine and isosorbide dinitrate on no-reflow/slow flow during rotational atherectomy

Acta Cardiologica

Volumn 64, Issue 2, 2009, Pages 225-230

  Tsao, Tien Ping ^a   Cheng, Shu Meng ^a   Cheng, Cheng Chung ^a   Yang, Shih Ping ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Adenosine; Coronary artery disease; Intracoronary; Isosorbide dinitrate; No reflowlslow flow phenomenon; Percutaneous coronary interventions

Indexed keywords

ADENOSINE; CREATINE KINASE; ISOSORBIDE DINITRATE;

AGED; ANGIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CREATINE KINASE BLOOD LEVEL; DRUG EFFICACY; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; INTRACORONARY INFUSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NO REFLOW PHENOMENON; PERCUTANEOUS CORONARY INTERVENTION; REVASCULARIZATION; ROTATIONAL ATHERECTOMY; SLOW FLOW PHENOMENON;

ADENOSINE; AGED; ATHERECTOMY, CORONARY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; CORONARY VESSELS; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRA-ARTERIAL; ISOSORBIDE DINITRATE; MALE; MONITORING, INTRAOPERATIVE; REGIONAL BLOOD FLOW; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 65349129386     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.64.2.2036142     Document Type: Article

References (33)

1. Worth DC, Leon MB, O'Neill W, Zacca N, Polissar NL, Buchbinder M. Rotational atherectomy multicenter registry: Acute results, complications and 6-month angiographic follow-up in 709 patients. J Am Coil Cardiol 1994; 24: 641-8.
2. Stertzer SH, Rosenblum J, Shaw RE, Sugeng I, Hidalgo B, Ryan C, Hansell HN, Murphy MC, Myler RK. Coronary rotational ablation: Initial experience in 302 procedures. J Am Coil Cardiol 1993; 21: 287-95.
3. Meany TB, Freidman HZ, O'Neill WW. Coronary rotational atherectomy: Clinical application. J Invasive Cardiol 1991; 3: 19-24.
4. Teirstein PS, Warth DC, Haq N, Jenkins NS, McCowan LC, Aubanel-Reidel P, Morris N, Ginsburg R. High speed rotational coronary atherectomy for patients with diffuse coronary artery disease. J Am Coll Cardiol 1991; 18; 694-701.
5. Fourrier JL, Bertrand ME, Auth DC, Lablanche JM, Gommeaux A, Brunetaud JM. Percutaneous coronary rotational angioplasty in humans: preliminary report. J Am Coll Cardiol 1989; 14: 1278-82.
6. Borrione M, Hall P, Almagor Y, Maiello L, Khlat B, Finci L, Colombo A. Treatment of simple and complex coronary stenosis using rotational ablation followed by low pressure balloon angioplasty. Cathet Cardiovasc Diagn 1993; 30: 131-7.
7. Safian RD, Freed M, Lichtenberg A, May MA, Juran N, Grines CL, O'Neill WW. Are residual stenoses after eximer laser angioplasty and coronary atherectomy due to inefficient or small devices? Comparison with balloon angioplasty. J Am Coll Cardiol 1993; 22: 628-34.
8. Ellis SG, Popma JJ, Buchbinder M, Franco I, Leon MB, Kent KM, Pichard AD, Satler LF, Topol EJ, Whitlow PL. Relation of clinical presentation, stenosis morphology, and operator technique to the procedural results of rotational atherectomy and rotational atherectomy-facilitated angioplasty. Circulation 1994; 89: 882-92.
9. Abbo KM, Dooris M, Glazier S, O'Neill WW, Byrd D, Grines CL, Safian RD. Features and outcome of no-reflow after percutaneous coronary intervention. Am J Cardiol 1995; 75: 778-82.
10. Levin TN, Holloway S, Feldman T. Acute and late clinical outcome after rotational atherectomy for complex coronary disease. Cathet Cardiovasc Diagn 1998; 45: 122-30.
11. Kloner RA, Ganote CE, Jannings RB. The no-reflow phenomenon after temporary coronary occlusion in the dog. J Clin Invest 1974; 54: 1496-1508.
12. Kloner RA, Ganote CE, Jennings RB, Reimer KA. Demonstration of the 'no-fellow' phenomenon in the dog heart after temporary ischemia. Recent Adv Stud Cardiac Struct Metab 1975; 10: 463-74.
13. 1 receptor blockade on glomerular hemodynamics: involvement of renin-angiotensin system. Am J Physiol 1994; 36: F783-F790.
14. 1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure. J Am Coll Cardiol 2000; 35: 56-9.
15. 1-adenosine receptor antagonist, protects against the decline in renal function observed with standard congestive heart failure therapy. J Am Coll Cardiol 2001; 37 Suppl A: 830-3.
16. Cerqueira MD, Verani MS, Schwaiger M, Heo J, Iskandrian AS. Safety profiles of adenosine stress perfusion imaging: results from the Adenoscan Multicenter Trial Registry. J Am Coll Cardiol 1994; 23: 384-9.
17. Piana RN, Paik GY, Moscucci M, Cohen DJ, Gibson CM, Kugelmass AD, Carrozza JP Jr, Kuntz RE, Baim DS. Incidence and treatment of 'no-reflow' after percutaneous coronary intervention. Circulation 1994; 89: 2514-8.
18. Hanna GP, Yhip P, Fujise K, Schroth GW, Rosales OR, Anderson HV, Smalling RW. Intracoronary adenosine administered during rotational atherectomy of complex lesions in native coronary arteries reduces the incidence of no-reflow phenomenon. Catheter Cardiovasc Interv 1999; 48: 275-8.
19. Porto I, Vaishali A, Mitchell ARJ. Pharmacological management of no reflow during percutaneous coronary intervention. Curr Vasc Pharm 2006; 4: 95-100.
20. Brosh D, Assali AR, Mager A, Porter A, Hasdai D, Teplitsky I, Rechavia E, Fuchs S, Battler A, Kornowski R. Effect of no-reflow during primary percutaneous coronary intervention for acute myocardial infarction on six-month mortality. Am J Cardiol 2007; 99: 442-5.
21. Rezkalla SH, Kloner RA. No-reflow phenomenon. Circulation 2002; 105: 656-62.
22. Demir I, Yilmaz H, Ermis C, Sancaktar O. Treatment of no-reflow phenomenon with verapamil after primary stent deployment during myocardial infarction. Jpn Heart J 2002; 43: 573-80.
23. Cecena FA, Hoelzinger DH. Transcatheter therapy of thrombotic-occlusive lesions in saphenous vein grafts. Am J Cardiol 1996; 78: 31-6.
24. Hillegass WB, Dean NA, Liao L, Rhinehart RG, Myers PR. Treatment of no-reflow and impaired flow with the nitric oxide donor nitroprusside following percutaneons coronary interventions: initial human clinical experience. J Am Coll Cardiol 2001; 37: 1335-43.
25. Barcin C, Denktas AE, Lennon RJ, Hammes L, Higano ST, Holmes DR Jr, Garratt KN, Lerman A. Comparison of combination therapy of adenosine and nitroprusside with adenosine alone in the treatment of angiographic no-reflow phenomenon. Catheter Cardiovasc Interv 2004; 61: 484-91.
26. Tsubokawa A, Ueda K, Sakamoto H, Iwase T, Tamaki S. Effect of intracoronary nicorandil administration on preventing no-reflow/slow flow phenomenon during rotational atherectomy. Circulation J 2002; 66: 1119-23.
27. Labrou A, Giannoglou G, Zioutas D, Fragakis N, Katsaris G, Louridas G. Trimetazidine administration minimizes myocardial damage and improves left ventricular function after percutaneous coronary intervention. Am J Cardiovasc Drugs 2007; 7: 143-50.
28. Stertzer SH, Pomerantsev EV, Fitzgerald PJ, Shaw RE, Walton AS, Singer AH, Yeung A, Yock PG, Oesterle SN. Effects of technique modification on immediate results of high speed rotational atherectomy in 710 procedures on 656 patients. Cathet Cardiovasc Diagn 1995; 36: 304-10.
29. Bersin RM, Simonton CA. Rotational and directional coronary atherectomy. Catheter Cardiovasc Interv 2003; 58: 485-99.
30. Kini A, Marmur JD, Duvvuri S, Dangas G, Choudhary S, Sharma SK. Rotational atherectomy: Improved procedural outcome with evolution of technique and equipment-single-centre results of first 1,000 patients. Catheter Cardiovasc Interv 1999; 46: 305-11.
31. Reisman M. Rotablator atherectomy. In: Freed M, Grines C, Safian RD, ed. The new manual of interventional cardiology. Physicians' Press, Birmingham, Michigan, 1996: 521-36.
32. Safian RD, Feldman T, Muller DW, Mason D, Schreiber T, Haik B, Mooney M, O'Neill WW. Coronary angioplasty and Rotablator atherectomy trial (CARAT): Immediate and late results of a prospective multicenter randomized trial. Catheter Cardiovasc Interv 2001; 53: 213-20.
33. Harding SA. The role of vasodilators in the prevention and treatment of no-reflow following percutaneous coronary intervention. Heart 2006; 92: 1191-93.